Literature DB >> 18808355

Role of Klebsiella oxytoca in antibiotic-associated diarrhea.

Ines Zollner-Schwetz1, Christoph Högenauer, Martina Joainig, Paul Weberhofer, Gregor Gorkiewicz, Thomas Valentin, Thomas A Hinterleitner, Robert Krause.   

Abstract

BACKGROUND: Klebsiella oxytoca was recently shown to be the causative agent of antibiotic-associated hemorrhagic colitis. Because it is unclear whether K. oxytoca also causes nonhemorrhagic antibiotic-associated diarrhea, our study investigated a possible association between K. oxytoca and that disorder.
METHODS: A total of 371 consecutive patients were recruited into 4 study groups: (1) group A+D+ (patients who received antibiotics and experienced diarrhea; n = 107), (2) group A+D- (patients who received antibiotics but did not experience diarrhea; np93), (3) group A-D+ (patients who experienced acute-onset diarrhea but did not receive antibiotics; n = 60), and (4) group A-D- (patients without diarrhea who did not receive antibiotics; n = 111). Stool samples were plated on MacConkey agar and K. oxytoca was identified using a standard test kit. Clostridium difficile was detected by a toxin A/B antigen test. K. oxytoca strains were tested for cytotoxicity with use of cell-culture assays.
RESULTS: In 15 of 371 stool samples, K. oxytoca strains were isolated during the study period. There was no significant difference in the distribution of K. oxytoca among the 4 study groups. Six of the 15 strains were found to be toxin producing. Three of the toxin-producing strains caused antibiotic-associated hemorrhagic colitis. No case of nonhemorrhagic antibiotic-associated diarrhea due to toxin-producing K. oxytoca was detected.
CONCLUSION: K. oxytoca is not the causative agent of nonhemorrhagic antibiotic-associated diarrhea. This is in contrast to the distinct clinical entity of antibiotic-associated hemorrhagic colitis. Testing for K. oxytoca is therefore only warranted for patients who experience bloody diarrhea during antibiotic therapy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18808355     DOI: 10.1086/592074

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  28 in total

1.  Enterotoxicity of a nonribosomal peptide causes antibiotic-associated colitis.

Authors:  Georg Schneditz; Jana Rentner; Sandro Roier; Jakob Pletz; Kathrin A T Herzog; Roland Bücker; Hanno Troeger; Stefan Schild; Hansjörg Weber; Rolf Breinbauer; Gregor Gorkiewicz; Christoph Högenauer; Ellen L Zechner
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-25       Impact factor: 11.205

2.  Antibiotic-associated haemorrhagic colitis: not always Clostridium difficile.

Authors:  Olalekan Akanbi; Nasir Saleem; Mohanad Soliman; Bibek Singh Pannu
Journal:  BMJ Case Rep       Date:  2017-06-14

Review 3.  Laboratory diagnosis of bacterial gastroenteritis.

Authors:  Romney M Humphries; Andrea J Linscott
Journal:  Clin Microbiol Rev       Date:  2015-01       Impact factor: 26.132

4.  Complete genome sequence of Klebsiella oxytoca E718, a New Delhi metallo-β-lactamase-1-producing nosocomial strain.

Authors:  Tsai-Lien Liao; Ann-Chi Lin; Elsa Chen; Tzu-Wen Huang; Yen-Ming Liu; Ya-Hui Chang; Jui-Fen Lai; Tsai-Ling Lauderdale; Jann-Tay Wang; Shan-Chwen Chang; Shih-Feng Tsai; Ying-Tsong Chen
Journal:  J Bacteriol       Date:  2012-10       Impact factor: 3.490

5.  Hepatic portal venous gas associated with Klebsiella oxytoca infection in the absence of preceding antibiotic treatment.

Authors:  Hidekazu Tanaka; Tomohiro Watanabe; Tomoyuki Nagai; Kosuke Minaga; Ken Kamata; Yoriaki Komeda; Masatoshi Kudo
Journal:  Clin J Gastroenterol       Date:  2019-02-09

6.  Delirium and other clinical factors with Clostridium difficile infection that predict mortality in hospitalized patients.

Authors:  Laurie R Archbald-Pannone; Timothy L McMurry; Richard L Guerrant; Cirle A Warren
Journal:  Am J Infect Control       Date:  2015-04-24       Impact factor: 2.918

Review 7.  Nosocomial diarrhea: evaluation and treatment of causes other than Clostridium difficile.

Authors:  Christopher R Polage; Jay V Solnick; Stuart H Cohen
Journal:  Clin Infect Dis       Date:  2012-06-14       Impact factor: 9.079

Review 8.  Clostridium difficile infection.

Authors:  Wiep Klaas Smits; Dena Lyras; D Borden Lacy; Mark H Wilcox; Ed J Kuijper
Journal:  Nat Rev Dis Primers       Date:  2016-04-07       Impact factor: 52.329

9.  Cytotoxic effects of Klebsiella oxytoca strains isolated from patients with antibiotic-associated hemorrhagic colitis or other diseases caused by infections and from healthy subjects.

Authors:  Martina M Joainig; Gregor Gorkiewicz; Eva Leitner; Paul Weberhofer; Ines Zollner-Schwetz; Irmgard Lippe; Gebhard Feierl; Robert Krause; Thomas Hinterleitner; Ellen L Zechner; Christoph Högenauer
Journal:  J Clin Microbiol       Date:  2010-01-06       Impact factor: 5.948

10.  Clarithromycin-induced haemorrhagic colitis.

Authors:  Ryosuke Miyauchi; Kensuke Kinoshita; Yasuharu Tokuda
Journal:  BMJ Case Rep       Date:  2013-08-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.